Join the Maryland Department of Commerce for a breakfast briefing on opportunities to partner with Australia in biotech. Learn about:
How Maryland companies can save up to 60% on early stage clinical trials by partnering with Australian companies.
Regulatory pathways, reimbursements, FDAA-TGA (the Australian equivalent of the FDA) harmonization, and R&D tax incentives.
The September 2019 MOU that Maryland signed with the State of Victoria, Australia, to develop a cooperative relationship in life sciences.
Please RSVP to Debra DeFazio at debra.defazio@maryland.gov by November 5.
Sponsored by: Maryland Department of Commerce